Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of the Femtosecond Laser System VisuMax for Refractive Correction of Hyperopia by Means of Lenticule Extraction

NCT02316041 is registered in ClinicalTrials.gov with Tilganga Institute of Ophthalmology as lead sponsor.

NCT NCT02316041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02316041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of the Femtosecond Laser System VisuMax for Refractive Correction of Hyperopia by Means of Lenticule Extraction
Lead sponsor
Tilganga Institute of Ophthalmology
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2014
Completion date
Not reported
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperopia